Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #193 on Viatris (VTRS)
DewDiligence
05/20/20 9:03 PM
#200 RE: DewDiligence #193
MYL’s decision whether to opt in for ]RVNC's] Botox-biosimilar program is expected by the end of May.